 |
인쇄하기
취소
|
Dong-A seeks to supply cycloserine to WHO agencies
Dong-A has obtained a prequalification approval from the World Health Organization (WHO) for its multidrug-resistant tuberculosis (MDR-TB) drug, Closerin (cycloserine), Korea’s leading drug maker said on Monday.
A company spokesman said Dong-A has become Korea’s first drug producer to win the WHO prequalification approval for cycloserine.
Cycloserine is an oral antibiotic effective agains...
A company spokesman said Dong-A has become Korea’s first drug producer to win the WHO prequalification approval for cycloserine.
Cycloserine is an oral antibiotic effective agains...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.